Health

GLP-1s may increase risk of osteoporosis and gout, new research finds

March 2, 2026

Recent research suggests that GLP-1 drugs, such as Ozempic and Wegovy, may pose an increased risk of osteoporosis and gout. The findings were presented at the American Academy of Orthopaedic Surgeons’ annual meeting, where the lead researcher noted concerns over patients experiencing significant tendon injuries from minor falls.

GLP-1s may increase risk of osteoporosis and gout, new research finds

Credit: Nbcnews

Key Highlights

GLP-1 drugs include Ozempic and Wegovy.
Research indicates a potential increase in osteoporosis and gout risk.
Study presented at the American Academy of Orthopaedic Surgeons’ annual meeting.
Lead researcher is Dr. John Horneff from the University of Pennsylvania.
Concerns arose after patients suffered serious tendon tears from minor injuries.

Sources

GLP-1s may increase risk of osteoporosis and gout, new research finds

This quick summary is automatically generated using AI based on reports from multiple news sources. The content has not been reviewed or verified by humans. For complete details, accuracy, and context, please refer to the original published articles.

GLP-1s may increase risk of osteoporosis and gout, new research finds

Key Highlights

Sources

Related Stories

As measles spreads in South Carolina, RFK Jr’s allies work to gut vaccine laws

Sirens, Explosions, Fear: Doctors Warn of PTSD Surge Among War-Affected Children

‘State can’t be whimsical’: Calcutta High Court upholds Rs 29 lakh cancer treatment claim for family of retired employee